Emerging studies are exploring whether GLP-1s could also help slow the progression of kidney disease, though current findings are still preliminary
C.et al (2023)
Cytoprotection Research has also examined protective effects in gastrointestinal tissues together with broader cellular stress responses
Losing weight through Semaglutide treatment can significantly reduce the risk of developing weight-related conditions such as type 2 diabetes, high blood pressure, and heart disease
No retatrutide is not approved by the MHRA or EMA as of 2025 and cannot be legally prescribed or dispensed in the UK
So the messaging framework, replace aspiration with empathy instead of transform your body, say, you know, find your fit through change instead of your new you, you know, say, close that meet you where you are right now